The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

The prevalence of serious inflammatory safety issues such as cytokine release syndrome and immune effector cell–associated ...

America has an Alzheimer’s problem, devastating families and driving soaring healthcare costs. More than 7 million people over 65 years old live with Alzheimer’s dementia today, a number predicted to ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...

Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...

Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...

Among patients with relapsed or refractory multiple myeloma, Tecvayli (teclistamab-cqyv) monotherapy was associated with a 71 ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine , the novel monoclonal antibody linavonkibart demonstrated the ...

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...